Ariel Berenstein

547 total citations
20 papers, 288 citations indexed

About

Ariel Berenstein is a scholar working on Molecular Biology, Epidemiology and Statistical and Nonlinear Physics. According to data from OpenAlex, Ariel Berenstein has authored 20 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Epidemiology and 3 papers in Statistical and Nonlinear Physics. Recurrent topics in Ariel Berenstein's work include Computational Drug Discovery Methods (3 papers), Complex Network Analysis Techniques (3 papers) and Bioinformatics and Genomic Networks (3 papers). Ariel Berenstein is often cited by papers focused on Computational Drug Discovery Methods (3 papers), Complex Network Analysis Techniques (3 papers) and Bioinformatics and Genomic Networks (3 papers). Ariel Berenstein collaborates with scholars based in Argentina, Spain and Switzerland. Ariel Berenstein's co-authors include Ariel Chernomoretz, Massimo Andreatta, Santiago J. Carmona, Fernán Agüero, María Paula Magariños, María Victoria Preciado, Laura I. Furlong, Janet Piñero, Mario Alejandro Lorenzetti and Abel González-Pérez and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Bioinformatics.

In The Last Decade

Ariel Berenstein

20 papers receiving 281 citations

Peers

Countries citing papers authored by Ariel Berenstein

Since Specialization

Citations

This map shows the geographic impact of Ariel Berenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariel Berenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariel Berenstein more than expected).

Fields of papers citing papers by Ariel Berenstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariel Berenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariel Berenstein. The network helps show where Ariel Berenstein may publish in the future.

Co-authorship network of co-authors of Ariel Berenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Ariel Berenstein. A scholar is included among the top collaborators of Ariel Berenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariel Berenstein. Ariel Berenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Semi-supervised integration of single-cell transcriptomics data 2024 ·Nature Communications ·Massimo Andreatta, (unknown), Paul Gueguen, David Gfeller, Ariel Berenstein, Santiago J. Carmona	13
2	scGate: marker-based purification of cell types from heterogeneous single-cell RNA-seq datasets 2022 ·Bioinformatics ·Massimo Andreatta, Ariel Berenstein, Santiago J. Carmona	38
3	Type 1 Insulin-Like Growth Factor Receptor Nuclear Localization in High-Grade Glioma Cells Enhances Motility, Metabolism, and In Vivo Tumorigenesis 2022 ·Frontiers in Endocrinology ·(unknown), María Celia Fernández, (unknown), (unknown), Marcela Venara, (unknown), Ariel Berenstein, (unknown), Ignacio Bergadá, Mariana Gutiérrez, Marcelo A. Martí, María R. González-Baró, P. Pennisi	4
4	Selecting putative drought-tolerance markers in two contrasting soybeans 2022 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), Björn Welin, Ariel Berenstein, Darío Fernández Do Porto, Adrián A. Vojnov, Atilio Pedro Castagnaro, Esteban Mariano Pardo	7
5	Effectiveness of Nifurtimox in the Treatment of Chagas Disease: a Long-Term Retrospective Cohort Study in Children and Adults 2022 ·Antimicrobial Agents and Chemotherapy ·(unknown), Ariel Berenstein, Guillermo Moscatelli, Samanta Moroni, Nicolás González, Griselda Ballering, Héctor Freilij, Jaime Altcheh	14
6	Comprehensive Evolutionary Analysis of Complete Epstein–Barr Virus Genomes from Argentina and Other Geographies 2021 ·Viruses ·(unknown), Ariel Berenstein, Carolina Torres, (unknown), (unknown), Guillermo Moscatelli, (unknown), Mario Alejandro Lorenzetti, María Victoria Preciado	11
7	Adverse Events Associated with Nifurtimox Treatment for Chagas Disease in Children and Adults 2020 ·Antimicrobial Agents and Chemotherapy ·Ariel Berenstein, (unknown), Guillermo Moscatelli, Samanta Moroni, Nicolás González, Facundo García‐Bournissen, Griselda Ballering, Héctor Freilij, Jaime Altcheh	20
8	Safety of standardised treatments for haematologic malignancies as regards to testicular endocrine function in children and teenagers 2019 ·Human Reproduction ·Romina P. Grinspon, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Patricia Bedecarrás, (unknown), (unknown), Silvia Gottlieb, Ariel Berenstein, María Gabriela Ropelato, Ignacio Bergadá, Luis Aversa, Rodolfo A. Rey	8
9	p.R209H GH1 variant challenges short stature assessment 2019 ·Growth Hormone & IGF Research ·(unknown), Débora Braslavsky, Paula Scaglia, Ana Keselman, Marı́a Gabriela Ballerini, María Gabriela Ropelato, (unknown), (unknown), Ariel Berenstein, Héctor Jasper, Horacio M. Domené, Rodolfo A. Rey, María Inés Pérez‐Millán, Sally A. Camper, Ignacio Bergadá	6
10	TDR Targets 6: driving drug discovery for human pathogens through intensive chemogenomic data integration 2019 ·Nucleic Acids Research ·(unknown), Ariel Berenstein, Santiago Videla, (unknown), Dhanasekaran Shanmugam, Ariel Chernomoretz, Fernán Agüero	36
11	Recombination rates along the entire Epstein Barr virus genome display a highly heterogeneous landscape 2018 ·Infection Genetics and Evolution ·Ariel Berenstein, Mario Alejandro Lorenzetti, María Victoria Preciado	13
12	Using contextual information for automatic triage of posts in a peer-support forum 2018 ·(unknown), Ariel Berenstein, David Milne, Rafael A. Calvo, Diego Fernández Slezak	5
13	A Bayesian approach to income inference in a communication network 2016 ·arXiv (Cornell University) ·(unknown), Ariel Berenstein, (unknown), (unknown), (unknown), Carlos Sarraute	4
14	Inference of Socioeconomic Status in a Communication Graph 2016 ·El Servicio de Difusión de la Creación Intelectual (National University of La Plata) ·(unknown), Ariel Berenstein, (unknown), (unknown), Carlos Sarraute	1
15	Uncovering disease mechanisms through network biology in the era of Next Generation Sequencing 2016 ·Scientific Reports ·Janet Piñero, Ariel Berenstein, Abel González-Pérez, Ariel Chernomoretz, Laura I. Furlong	25
16	A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases 2016 ·PLoS neglected tropical diseases ·Ariel Berenstein, María Paula Magariños, Ariel Chernomoretz, Fernán Agüero	33
17	A Bayesian approach to income inference in a communication network 2016 ·arXiv (Cornell University) ·(unknown), Ariel Berenstein, (unknown), (unknown), (unknown), Carlos Sarraute	8
18	Reprogramming human A375 amelanotic melanoma cells by catalase overexpression: Upregulation of antioxidant genes correlates with regression of melanoma malignancy and with malignant progression when downregulated 2016 ·Oncotarget ·(unknown), Irene L. Ibañez, Ariel Berenstein, Cintia Notcovich, (unknown), Fábio Klamt, Ariel Chernomoretz, Hebe Durán	30
19	Mining the Modular Structure of Protein Interaction Networks 2015 ·PLoS ONE ·Ariel Berenstein, Janet Piñero, Laura I. Furlong, Ariel Chernomoretz	5
20	Using coevolution to improve protein subfamily classification 2015 ·BMC Bioinformatics ·Franco L. Simonetti, Martin Banchero, Ariel Berenstein, Ariel Chernomoretz, Cristina Marino‐Buslje	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact